Grufity logo
Grufity logo

Latest TANG CAPITAL MANAGEMENT LLC Stock Portfolio

$1.97Billion | No. of Holdings #51

TANG CAPITAL MANAGEMENT LLC Performance

2026 Q1+1.21%
YTD+1.21%
2025+36.74%

About TANG CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, TANG CAPITAL MANAGEMENT LLC reported an equity portfolio of $2 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of TANG CAPITAL MANAGEMENT LLC are AUPH, CELC, MIRM. The fund has invested 9.2% of it's portfolio in AURINIA PHARMACEUTICALS INC and 6.1% of portfolio in CELCUITY INC. <br><br> The fund managers got completely rid off AVIDITY BIOSCIENCES INC (RNA), VERTEX PHARMACEUTICALS INC (VRTX) and TRAVERE THERAPEUTICS INC (TVTX) stocks. They significantly reduced their stock positions in MODERNA INC (MRNA), ERASCA INC (ERAS) and ALTIMMUNE INC (ALT). TANG CAPITAL MANAGEMENT LLC opened new stock positions in COMPASS PATHWAYS PLC (CMPS), JANUX THERAPEUTICS INC (JANX) and AGIOS PHARMACEUTICALS INC (AGIO). The fund showed a lot of confidence in some stocks as they added substantially to CORCEPT THERAPEUTICS INC (CORT), STATE STR SPDR S&P 500 ETF T (SPY) and INSMED INC (INSM).
TANG CAPITAL MANAGEMENT LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$1.97Billion
  as of May 15, 2026

TANG CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that TANG CAPITAL MANAGEMENT LLC made a return of 1.21% in the last quarter. In trailing 12 months, it's portfolio return was 50.28%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
compass pathways plc22,132,200
janux therapeutics inc6,950,000
agios pharmaceuticals inc3,383,000
lexicon pharmaceuticals inc623,532
New stocks bought by TANG CAPITAL MANAGEMENT LLC

Additions

Ticker% Inc.
corcept therapeutics inc856
state str spdr s&p 500 etf t460
insmed inc333
capricor therapeutics inc99.99
ani pharmaceuticals inc46.96
crescent biopharma inc.32.97
precigen inc14.24
aurinia pharmaceuticals inc7.94
Additions to existing portfolio by TANG CAPITAL MANAGEMENT LLC

Reductions

Ticker% Reduced
moderna inc-85.57
erasca inc-77.78
altimmune inc-68.75
evolus inc-61.22
abeona therapeutics inc-60.00
neumora therapeutics inc.-54.52
lenz therapeutics inc-47.86
coherus oncology inc-30.75
TANG CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker$ Sold
ventyx biosciences inc-25,410,400
immunitybio inc-4,620,000
teladoc health inc-9,800,000
verastem inc-8,258,930
avidity biosciences inc-64,917,000
biocryst pharmaceuticals inc-6,240,000
travere therapeutics inc-26,747,000
dynavax technologies corp-8,556,800
TANG CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

TANG CAPITAL MANAGEMENT LLC has about 74.5% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare74.5
Others25.5

Market Cap. Distribution

TANG CAPITAL MANAGEMENT LLC has about 2.7% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • MID-CAP
  • UNALLOCATED
  • LARGE-CAP
  • MICRO-CAP
Category%
SMALL-CAP36.7
MID-CAP33
UNALLOCATED25.5
LARGE-CAP2.7
MICRO-CAP1.9

Stocks belong to which Index?

About 62.2% of the stocks held by TANG CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200062.2
Others37.2
Top 5 Winners (%)%
ERAS
erasca inc
204.7 %
dianthus therapeutics inc
103.6 %
AGLE
spyre therapeutics inc
54.0 %
AVIR
atea pharmaceuticals inc
50.7 %
crescent biopharma inc.
45.0 %
Top 5 Winners ($)$
AGLE
spyre therapeutics inc
33.5 M
KALV
kalvista pharmaceuticals inc
18.2 M
MIRM
mirum pharmaceuticals inc
16.6 M
kiniksa pharmaceuticals intl
15.6 M
CELC
celcuity inc
15.1 M
Top 5 Losers (%)%
WVE
wave life sciences ltd
-57.4 %
NUVB
nuvation bio inc
-47.3 %
HRTX
heron therapeutics inc
-38.5 %
VRDN
viridian therapeutics inc
-37.1 %
DERM
journey med corp
-36.6 %
Top 5 Losers ($)$
VRDN
viridian therapeutics inc
-20.7 M
NUVB
nuvation bio inc
-16.4 M
TARS
tarsus pharmaceuticals inc
-13.9 M
AUPH
aurinia pharmaceuticals inc
-13.3 M
IMCR
immunocore hldgs plc
-12.0 M

TANG CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC has 51 stocks in it's portfolio. About 57.9% of the portfolio is in top 10 stocks. VRDN proved to be the most loss making stock for the portfolio. AGLE was the most profitable stock for TANG CAPITAL MANAGEMENT LLC last quarter.

$1.97BTotal Value
79.00Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of TANG CAPITAL MANAGEMENT LLC, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AUPH
Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

AUPH
TANG CAPITAL MANAGEMENT LLC's holding in Aurinia Pharmaceuticals Inc over time
9.2%12,229,500
$181.24M
9.2%
increased 7.94 percentadded
BNTX
Biontech Se

Biontech Se

BNTX
TANG CAPITAL MANAGEMENT LLC's holding in Biontech Se over time
2.12%470,000
$41.77M
2.12%
unchanged 0 percentunchanged
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
TANG CAPITAL MANAGEMENT LLC's holding in Compass Pathways Plc over time
1.12%4,002,200
$22.13M
1.12%
new position